<p>In this episode Dr. Slavin welcomes Dr. Judy Garber, Professor of Medicine at Harvard Medical School, Chief of Division of Cancer Genetics and Prevention at the Dana Farber Institute, and Susan F. Smith Chair. Together, they discuss the OlympiA study and outcomes that have influenced industry guidelines.</p>

In this episode Dr. Slavin welcomes Dr. Judy Garber, Professor of Medicine at Harvard Medical School, Chief of Division of Cancer Genetics and Prevention at the Dana Farber Institute, and Susan F. Smith Chair. Together, they discuss the OlympiA study and outcomes that have influenced industry guidelines.

What we’ve learned from the OlympiA study, with Dr. Judy Garber

Hosted by Dr. Thomas Slavin, Chief Medical Officer for Myriad Genetics, Inside the GENOME will be exploring the world of cutting-edge cancer genetics with 2-3 episodes per month. Dr. Slavin will interview those on the front lines of cancer, and those advancing the science of cancer prevention, diagnosis, and treatment. Inside the GENOME - Genetics, Oncology and Me.

Share What we’ve learned from the OlympiA study, with Dr. Judy Garber

Sign up to save your podcasts

What we’ve learned from the OlympiA study, with Dr. Judy Garber

What we’ve learned from the OlympiA study, with Dr. Judy Garber